Therapeutic Classification: antianxiety agents, sedative/hypnotics
Pharmacologic Classification: benzodiazepines
Absorption: Well absorbed following oral administration. Absorption is slower than with other benzodiazepines.
Distribution: Widely distributed. Crosses the blood-brain barrier.
Protein Binding: 97%.
Half-Life: 515 hr.
Contraindicated in:
Use Cautiously in:
CV: tachycardia
Derm: rash
EENT: blurred vision
GI: constipation, diarrhea, drug-induced hepatitis, nausea, vomiting
GU: urinary problems
Hemat: leukopenia
Neuro: dizziness, drowsiness, confusion, depression, hangover, headache, impaired memory, paradoxical excitation, slurred speech
Resp: respiratory depression
Misc: physical dependence, psychological dependence, tolerance
Drug-drug:
Use with opioids or other CNS depressants, including other benzodiazepines, nonbenzodiazepine sedative/hypnotics, anxiolytics, general anesthetics, muscle relaxants, antipsychotics, and alcohol may cause profound sedation, respiratory depression, coma, and death; reserve concurrent use for when alternative treatment options are inadequate.
Drug-Natural Products:
Prolonged high-dose therapy may lead to psychological or physical dependence. Restrict the amount of drug available to patient. Assess regularly for continued need for treatment.
Assess risk for addiction, abuse, or misuse prior to administration and periodically during therapy.
Lab Test Considerations:
Medication should be tapered at completion of therapy (taper by 0.5 mg every 3 days). Sudden cessation of medication may lead to withdrawal (insomnia, irritability, nervousness, tremors).
Caution patient not to stop taking oxazepam without consulting health care provider. Abrupt withdrawal may cause sweating, vomiting, muscle cramps, tremors, and seizures; may be life-threatening.
Advise patient that oxazepam is a drug with known abuse potential. Protect it from theft, and never give to anyone other than the individual for whom it was prescribed. Store out of sight and reach of children and in a location not accessible by others.
Advise patient to avoid the use of alcohol or other CNS depressants, including opioids, concurrently with lorazepam; may cause respiratory depression and overdose. Instruct patient to consult health care provider before taking Rx, OTC, or herbal products concurrently with this medication.